Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.

This bill (S 4042) requires New Jersey's Department of Health (DOH) to establish a program purchasing and distributing xylazine test strips to harm reduction service providers. It mandates DOH to oversee bulk purchasing, distribute strips upon request to authorized providers, and create a public website with information about the test strips and their availability. The program will be funded through federal grants and a new appropriation from the state General Fund. The bill directly affects harm reduction organizations providing services like needle exchanges and overdose prevention, enabling them to test drugs for xylazine - a dangerous veterinary sedative sometimes mixed with opioids - to improve user safety.